Everyone remembers their first flu shot (Ouch!), but recent developments in Georgia’s health sciences and bioengineering centers may revolutionize how vaccines are administered.
Scientists at Emory University, in collaboration with Georgia Tech, have successfully completed a phase I clinical trial of a microneedle skin patch, designed to deliver easy and painless immunity against influenza. Instead of being pinched by a long hypodermic needle, study participants were given a small, self-adhesive skin patch embedded with tiny dissolvable needles that administered the flu vaccine safely. The researchers aim to leverage the patch to get more people vaccinated and help medical centers & clinics save money.
Results of the study were published June 27, 2017 in the medical journal The Lancet. The research was supported by the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health.
Read the full story here: http://www.news.emory.edu/stories/2017/06/microneedles_flu_vaccine_patch/index.html